series-c
Stage
1
Investors
About
Kaleido Biosciences develops microbiome-based therapies that target diseases by modulating metabolic pathways and bacterial populations to improve patient health.
Explore Kaleido Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.